187 related articles for article (PubMed ID: 33805628)
1. Doxorubicin Encapsulation in Carbon Nanotubes Having Haeckelite or Stone-Wales Defects as Drug Carriers: A Molecular Dynamics Approach.
Contreras L; Villarroel I; Torres C; Rozas R
Molecules; 2021 Mar; 26(6):. PubMed ID: 33805628
[TBL] [Abstract][Full Text] [Related]
2. Carbon Nanotubes Having Haeckelite Defects as Potential Drug Carriers. Molecular Dynamics Simulation.
Torres C; Villarroel I; Rozas R; Contreras L
Molecules; 2019 Nov; 24(23):. PubMed ID: 31771295
[TBL] [Abstract][Full Text] [Related]
3. Preparation and properties of carbon nanotube (Fe)/hydroxyapatite composite as magnetic targeted drug delivery carrier.
Li H; Sun X; Li Y; Li B; Liang C; Wang H
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():222-229. PubMed ID: 30678906
[TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics insight of interaction between the functionalized-carbon nanotube and cancerous cell membrane in doxorubicin delivery.
Kordzadeh A; Zarif M; Amjad-Iranagh S
Comput Methods Programs Biomed; 2023 Mar; 230():107332. PubMed ID: 36603233
[TBL] [Abstract][Full Text] [Related]
5. Adsorption and encapsulation of the drug doxorubicin on covalent functionalized carbon nanotubes: A scrutinized study by using molecular dynamics simulation and quantum mechanics calculation.
Kordzadeh A; Amjad-Iranagh S; Zarif M; Modarress H
J Mol Graph Model; 2019 May; 88():11-22. PubMed ID: 30616088
[TBL] [Abstract][Full Text] [Related]
6. Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma.
Chaudhuri P; Soni S; Sengupta S
Nanotechnology; 2010 Jan; 21(2):025102. PubMed ID: 19955607
[TBL] [Abstract][Full Text] [Related]
7. Understanding the co-loading and releasing of doxorubicin and paclitaxel using chitosan functionalized single-walled carbon nanotubes by molecular dynamics simulations.
Karnati KR; Wang Y
Phys Chem Chem Phys; 2018 Apr; 20(14):9389-9400. PubMed ID: 29565091
[TBL] [Abstract][Full Text] [Related]
8. Carbon Nanotubes: An Emerging Drug Delivery Carrier in Cancer Therapeutics.
Panigrahi BK; Nayak AK
Curr Drug Deliv; 2020; 17(7):558-576. PubMed ID: 32384030
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulation study of doxorubicin adsorption on functionalized carbon nanotubes with folic acid and tryptophan.
Arabian T; Amjad-Iranagh S; Halladj R
Sci Rep; 2021 Dec; 11(1):24210. PubMed ID: 34930942
[TBL] [Abstract][Full Text] [Related]
10. Anticancer DOX delivery system based on CNTs: Functionalization, targeting and novel technologies.
Yaghoubi A; Ramazani A
J Control Release; 2020 Nov; 327():198-224. PubMed ID: 32763433
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulation of doxorubicin adsorption on a bundle of functionalized CNT.
Izadyar A; Farhadian N; Chenarani N
J Biomol Struct Dyn; 2016 Aug; 34(8):1797-805. PubMed ID: 26375507
[TBL] [Abstract][Full Text] [Related]
12. Description of Release Process of Doxorubicin from Modified Carbon Nanotubes.
Chudoba D; Jażdżewska M; Łudzik K; Wołoszczuk S; Juszyńska-Gałązka E; Kościński M
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769431
[TBL] [Abstract][Full Text] [Related]
13. Pegylated and folic acid functionalized carbon nanotubes as pH controlled carriers of doxorubicin. Molecular dynamics analysis of the stability and drug release mechanism.
Wolski P; Nieszporek K; Panczyk T
Phys Chem Chem Phys; 2017 Mar; 19(13):9300-9312. PubMed ID: 28323298
[TBL] [Abstract][Full Text] [Related]
14. Carbon nanotubes as an emerging nanocarrier for the delivery of doxorubicin for improved chemotherapy.
Chadar R; Afzal O; Alqahtani SM; Kesharwani P
Colloids Surf B Biointerfaces; 2021 Dec; 208():112044. PubMed ID: 34419810
[TBL] [Abstract][Full Text] [Related]
15. A new family of folate-decorated and carbon nanotube-mediated drug delivery system: synthesis and drug delivery response.
Huang H; Yuan Q; Shah JS; Misra RD
Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1332-9. PubMed ID: 21514336
[TBL] [Abstract][Full Text] [Related]
16. Study of folate-based carbon nanotube drug delivery systems targeted to folate receptor α by molecular dynamic simulations.
Jiang Y; Wang C; Zhang M; Liu L; Gao X; Zhang S; Ye D
Int J Biol Macromol; 2023 Jul; 244():125386. PubMed ID: 37327924
[TBL] [Abstract][Full Text] [Related]
17. pH-Sensitive Co-Adsorption/Release of Doxorubicin and Paclitaxel by Carbon Nanotube, Fullerene, and Graphene Oxide in Combination with
Rezaian M; Maleki R; Dahri Dahroud M; Alamdari A; Alimohammadi M
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30380660
[TBL] [Abstract][Full Text] [Related]
18. TRPV1 channel as a target for cancer therapy using CNT-based drug delivery systems.
Ortega-Guerrero A; Espinosa-Duran JM; Velasco-Medina J
Eur Biophys J; 2016 Jul; 45(5):423-33. PubMed ID: 26872481
[TBL] [Abstract][Full Text] [Related]
19. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes.
Mehra NK; Jain NK
J Drug Target; 2013 Sep; 21(8):745-58. PubMed ID: 23822734
[TBL] [Abstract][Full Text] [Related]
20. An MD-based systematic study on the mechanical characteristics of a novel hybrid CNT/graphene drug carrier.
Mohebali M; Rezapour N; Shadmani P; Montazeri A
J Mol Model; 2020 Aug; 26(9):241. PubMed ID: 32814981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
